Doctor profile · Federal record
Dr. Mayur Patel, M.D.
Rheumatology Physician (CMS: Rheumatology) · Rheumatology Physician · Burlington, NC
- NPI 1386802205
- Accepts Medicare
- 18 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
1234 Huffman Mill Road
Burlington, NC 272158700
(336) 538-1234
fax (336) 584-6811 - Additional location
-
853 N Church St, Suite 720A
Spartanburg, SC 293033098
(864) 560-6844
fax (864) 560-7015
Credentials & registration
- NPI registered
- May 2008 — 18 yrs on file
- Profile last updated
- April 10, 2023
- Year of graduation
- 2008 — 18 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State licenses (2)
- North Carolina #2013-00683 · South Carolina #35638
- Medicaid
- SC #356386
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1386802205. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
98,148
Distinct HCPCS
10
Medicare allowed
$1,305,933
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 66,801 | 21 | $5 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 12,725 | 23 | $42 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 8,850 | 11 | $13 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 5,080 | 29 | $33 | |
J0897 |
Injection, denosumab, 1 mg | 960 | 13 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 542 | 248 | $119 | |
36415 |
Insertion of needle into vein for collection of blood sample | 378 | 219 | $8 | |
96372 |
Injection of drug or substance under skin or into muscle | 352 | 36 | $13 | |
85652 |
Red blood cell sedimentation rate, to detect inflammation, automated | 322 | 182 | $3 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 280 | 162 | $7 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 3,635. This provider delivers 27× the peer median.Open Payments
Industry payments received
All-time total
$104
Transactions
6
Manufacturers
3
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, Inc. | 4 | $62.36 | |
| UCB, Inc. | 1 | $23.49 | |
| Novartis Pharmaceuticals Corporation | 1 | $18.06 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
4,355
Patients
1,268
Total drug cost
$2,255,634
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Methotrexate (Methotrexate Sodium) | Brand | 983 | 243 | $29,852 |
| Hydroxychloroquine Sulfate | Generic | 914 | 236 | $45,842 |
| Prednisone | Generic | 557 | 241 | $4,260 |
| Gabapentin | Generic | 338 | 97 | $3,076 |
| Allopurinol | Generic | 318 | 100 | $4,435 |
| Celecoxib | Generic | 215 | 56 | $5,284 |
| Humira(Cf) Pen (Adalimumab) | Brand | 201 | 25 | $1,481,260 |
| Leflunomide | Generic | 139 | 50 | $6,507 |
| Colchicine | Generic | 135 | 50 | $9,233 |
| Folic Acid | Generic | 118 | 48 | $616 |
Frequently asked questions
What is Dr. Mayur Patel's medical specialty?
Dr. Mayur Patel practices Rheumatology Physician in Burlington, NC.
Where does Dr. Mayur Patel practice?
Dr. Mayur Patel practices at 1234 Huffman Mill Road, Burlington, NC 272158700. Office phone: 3365381234.
What is Dr. Mayur Patel's NPI?
Dr. Mayur Patel's National Provider Identifier (NPI) is 1386802205, issued by NPPES.
Does Dr. Mayur Patel accept Medicare assignment?
Yes. Dr. Mayur Patel accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mayur Patel commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602). Source: CMS Medicare Physician & Other Practitioners file.